Pfizer Policy Effort Adjusts To Obama Era: Adds Greg Simon, From Obama Transition
This article was originally published in The Pink Sheet Daily
Pfizer is aligning its internal policy shop to get more in tune with Democratic Washington. The first major staff change is Greg Simon moving from Faster Cures advocacy group to become senior VP-worldwide policy.
You may also be interested in...
Biotech Equity Crowdfunding Gets A Head Start Overseas
Can crowdfunding fill the biotech capital gap? In the US, new services are jockeying at the starting gate even though the government’s final rules won’t be ready soon, while in Europe the experiment has begun in earnest.
PhRMA Has Labor Support For Extended Biologics Exclusivity
The Sheet Metal Workers' International Association labor union supports the 12-year data exclusivity for biologics embodied in Sen. Edward Kennedy's follow-on biologics bill
The Evolving Door? What Having A ‘Big Data’ Commissioner Might Mean For US FDA
Robert Califf’s nomination to return as FDA commissioner will raise protests about a ‘revolving door’ pathway between industry and agency. But, in this case, it may be more apt to talk about how Califf’s time outside FDA led to evolving views on the role of big data in drug regulation.